| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |